When Does Wegovy Start Working? A Realistic Timeline

Short answer: Wegovy starts working on your appetite within the first days to weeks — many people notice less hunger and earlier fullness before the scale moves much — but meaningful weight loss is a slow, months-long curve, not a quick drop. The two timelines are different, and confusing them is the single biggest reason people feel discouraged early. This article separates the appetite timeline from the weight timeline, ties both to the actual phase-3 trial data, and is honest about what the drug does not do overnight. None of this is medical advice for your situation — your prescriber sets your dose and your pace.

A quick grounding fact: Wegovy is semaglutide, a GLP-1 receptor agonist. It does not "burn fat." It works mainly by acting on appetite and the brain's regulation of eating — slowing gastric emptying and reducing hunger and food intake — so you eat less without white-knuckling it³. That mechanism is why the appetite effect shows up fast but the weight effect takes time: eating somewhat less each day adds up gradually, not instantly.

Week by week: the appetite timeline (fast)

The part people feel first is reduced appetite, and it tends to arrive early — often within the first one to two weeks on even the lowest starting dose. In a controlled study of semaglutide 2.4 mg (the Wegovy maintenance dose) in adults with obesity, the drug lowered energy intake and reduced hunger and food cravings while slowing gastric emptying, which is the mechanistic fingerprint of that early "I'm full faster, I think about food less" experience⁵. Similar appetite and energy-intake reductions show up in the broader semaglutide literature⁴.

What this looks like in real life:

• •Days to first 2 weeks (0.25 mg starting dose): Some people notice smaller portions feel satisfying, snacking urges fade, and rich or greasy foods become less appealing. Others feel little at this low dose — that is normal, because 0.25 mg is a starter dose meant to ease side effects, not to drive weight loss.
• •As the dose steps up (every ~4 weeks): The appetite effect generally strengthens with each increase, which is exactly why Wegovy is titrated upward over about 16–20 weeks rather than started high.

Important honesty check: an early appetite change is encouraging, but it is not the same as weight loss, and a lack of dramatic appetite change in the first weeks does not mean the drug is failing — the low starting dose is deliberately gentle.

Month by month: the weight timeline (slow)

This is where expectations need recalibrating. Real weight loss with Wegovy is a gradual, months-long slope, and the trial data make the pace concrete.

In STEP 1, the pivotal 68-week trial of semaglutide 2.4 mg in adults with overweight or obesity (without diabetes), the average participant lost about 15% of body weight — but that result came at week 68, after a full titration and many months at the maintenance dose¹. The weight curve in that trial declines steadily over roughly the first ~60 weeks before flattening; there is no sudden week-4 collapse on the scale.

A realistic, trial-shaped expectation:

• •First 4 weeks: Often little or no scale change, or a few pounds. You are still on starter doses. Judge progress by appetite, not the scale.
• •Months 2–4: As the dose climbs toward maintenance, weight loss typically becomes more visible and steady.
• •Months 4–12+: This is where the bulk of the STEP 1 ~15% average accrues, assuming you reach and tolerate the maintenance dose¹.

The same slow-and-steady pattern appears across the diabetes trials. In SUSTAIN 1, once-weekly semaglutide produced significant weight reduction versus placebo over 30 weeks — again, a trajectory measured in months, not days².

"It's been a month and barely anything happened"

This is the most common worry, and usually it is not a problem. The likely reasons:

1. 1.You are still in titration. The first ~16–20 weeks step the dose up gradually; the full appetite and weight effect is meant to arrive after you reach maintenance, not during the ramp.
2. 2.The scale lags the appetite change. Eating modestly less each day produces weight loss that is real but slow to register.
3. 3.Individual response varies. Trial averages are averages — some people lose more, some less, and a minority respond minimally. Your prescriber tracks this and decides whether to continue, adjust, or reconsider.

If you have reached the maintenance dose and given it a fair stretch (think months, not weeks) with genuinely no response, that is a conversation to have with your prescriber — not a reason to self-escalate the dose. For how the dose ladder actually works, see our guide to semaglutide dosing and side effects.

Why the slow start is a feature, not a bug

The deliberate, weeks-long titration exists to reduce the nausea, constipation, and other GI side effects that come from ramping a GLP-1 too fast (we cover how to handle those in Wegovy constipation & diarrhea: managing GI side effects). Starting low and going slow is what makes the medicine tolerable enough to stay on long enough to reach that ~15% — and staying on it matters. In STEP 4, people who had already lost weight on semaglutide and then switched to placebo regained weight, while those who continued the drug kept losing⁶. In other words, the timeline does not "finish" — the benefit is tied to ongoing treatment, a point we cover in depth in what happens when you stop semaglutide.

It's not only about the number on the scale

Worth keeping in view: Wegovy's value is not purely cosmetic weight. In the large SELECT trial, semaglutide reduced the risk of major cardiovascular events (heart attack, stroke, and cardiovascular death) in adults with overweight or obesity and established heart disease, without diabetes⁷. That benefit, too, accrued over time — SELECT followed participants for years. So "is it working?" is a broader question than the week-4 scale reading. The kind of weight you lose matters too: about a quarter to a third of it is lean mass unless you intervene, which is why protein and resistance training are worth building in from the start — see will semaglutide make you lose muscle?.

A note on compounded and grey-market semaglutide

Every timeline figure above comes from trials of FDA-approved, standardized semaglutide at known doses⁸. Compounded semaglutide sold by some telehealth and med-spa sources is not the same product: dose accuracy and formulation can vary, so you cannot assume the STEP 1 timeline transfers to it. Products from unregulated online sellers are riskier still. If you are choosing a source, our best semaglutide providers guide ranks options on price and oversight, and our pillar Semaglutide: How It Works, Results & Side Effects lays out the full evidence picture.

The honest bottom line

Expect appetite changes within the first days to weeks, and expect the scale to move slowly over months, with the bulk of the trial-average ~15% loss accruing across the better part of a year on the maintenance dose¹. A quiet first month is normal and usually means you are still titrating, not that the drug failed. Judge the early weeks by hunger, not pounds; let your prescriber set the pace; and remember the benefit lasts only as long as treatment does⁶. This is general education, not a prediction for you specifically — your results, side effects, and dose are individual.